tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
PremiumCompany AnnouncementsBolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
5M ago
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
Premium
Ratings
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
5M ago
Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright
Premium
The Fly
Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright
5M ago
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
PremiumThe FlyBolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
7M ago
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
Premium
The Fly
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
7M ago
Bolt Biotherapeutics Inc trading halted, news pending
Premium
The Fly
Bolt Biotherapeutics Inc trading halted, news pending
9M ago
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
PremiumRatingsCautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
10M ago
Cautious Hold Rating on Bolt Biotherapeutics Amid Promising Clinical Data and Financial Uncertainty
Premium
Ratings
Cautious Hold Rating on Bolt Biotherapeutics Amid Promising Clinical Data and Financial Uncertainty
10M ago
Bolt Biotherapeutics price target lowered to $1 from $1.25 at Stifel
Premium
The Fly
Bolt Biotherapeutics price target lowered to $1 from $1.25 at Stifel
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100